Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ominedo Pharmaceutical is a Japanese pharmaceutical company specializing in the development and manufacture of traditional Kampo medicines and over-the-counter (OTC) drugs. Established in 1923 and based in Nara Prefecture, the company has a long history of producing herbal extracts and finished formulations. Ominedo operates as both a proprietary brand manufacturer and a contract manufacturing organization (CMO), providing high-quality extraction services for other pharmaceutical firms. Their product line includes a variety of traditional remedies for respiratory, digestive, and inflammatory conditions, such as Kakkonto and Shoseiryuto. The company maintains advanced manufacturing facilities that adhere to strict Good Manufacturing Practice (GMP) standards to ensure the safety and efficacy of their botanical products. Ominedo is particularly recognized for its expertise in the standardized extraction of active ingredients from raw medicinal herbs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ominedo Pharmaceutical Industry Company.